Haakon Ragde

6.1k total citations
83 papers, 4.5k citations indexed

About

Haakon Ragde is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Oncology. According to data from OpenAlex, Haakon Ragde has authored 83 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 18 papers in Immunology and 17 papers in Oncology. Recurrent topics in Haakon Ragde's work include Prostate Cancer Diagnosis and Treatment (37 papers), Prostate Cancer Treatment and Research (36 papers) and Immunotherapy and Immune Responses (18 papers). Haakon Ragde is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (37 papers), Prostate Cancer Treatment and Research (36 papers) and Immunotherapy and Immune Responses (18 papers). Haakon Ragde collaborates with scholars based in United States, Austria and Germany. Haakon Ragde's co-authors include John C. Blasko, Peter Grimm, Gerald M. Kenny, Alton L. Boynton, B.A. Tjoa, G.P. Murphy, J. William McRoberts, William Cavanagh, M.J. Troychak and M. Rogers and has published in prestigious journals such as Science, JAMA and Journal of Clinical Oncology.

In The Last Decade

Haakon Ragde

81 papers receiving 4.2k citations

Peers

Countries citing papers authored by Haakon Ragde

Since Specialization

Citations

This map shows the geographic impact of Haakon Ragde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haakon Ragde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haakon Ragde more than expected).

Fields of papers citing papers by Haakon Ragde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haakon Ragde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haakon Ragde. The network helps show where Haakon Ragde may publish in the future.

Co-authorship network of co-authors of Haakon Ragde

This figure shows the co-authorship network connecting the top 25 collaborators of Haakon Ragde. A scholar is included among the top collaborators of Haakon Ragde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haakon Ragde. Haakon Ragde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemotherapy Followed by Syngeneic Dendritic Cell Injection in the Mouse: Findings and Implications for Human Treatment 2007 ·Urology ·William Cavanagh, B.A. Tjoa, Haakon Ragde	4
2	An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow‐up 2002 ·Cancer ·Frank A. Vicini, Alvaro A. Martinez, Gerald E. Hanks, A.L. Hanlon, Brian J. Miles, (unknown), (unknown), Haakon Ragde, Jeffrey D. Forman, James Fontanesi, Larry L. Kestin, György Kovács, Louis Denis, Kevin M. Slawin, Peter T. Scardino	42
3	Modern prostate brachytherapy 2000 ·CA A Cancer Journal for Clinicians ·Haakon Ragde, Gordon L. Grado, B. Nadir, Abdel‐Aziz A. Elgamal	79
4	GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial 1999 ·The Prostate ·S.J. Simmons, B.A. Tjoa, M. Rogers, A. Elgamal, Gerald M. Kenny, Haakon Ragde, M.J. Troychak, Alton L. Boynton, G.P. Murphy	59
5	Follow-up evaluation of a phase II prostate cancer vaccine trial 1999 ·The Prostate ·B.A. Tjoa, S.J. Simmons, A. Elgamal, M. Rogers, Haakon Ragde, Gerald M. Kenny, M.J. Troychak, Alton L. Boynton, G.P. Murphy	121
6	Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease 1999 ·The Prostate ·G.P. Murphy, B.A. Tjoa, S.J. Simmons, (unknown), Victoria Bowes, Haakon Ragde, M. Rogers, A. Elgamal, Gerald M. Kenny, Oliver E. Cobb, Robert C. Ireton, M.J. Troychak, Michael L. Salgaller, Alton L. Boynton	197
7	Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment 1999 ·The Prostate ·G.P. Murphy, B.A. Tjoa, S.J. Simmons, Haakon Ragde, M. Rogers, A. Elgamal, Gerald M. Kenny, M.J. Troychak, Michael L. Salgaller, Alton L. Boynton	153
8	Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides 1998 ·The Prostate ·B.A. Tjoa, S.J. Simmons, Victoria Bowes, Haakon Ragde, M. Rogers, A. Elgamal, Gerald M. Kenny, Oliver E. Cobb, Robert C. Ireton, M.J. Troychak, Michael L. Salgaller, Alton L. Boynton, G.P. Murphy	207
9	Reduction of radioactive seed embolization to the lung following prostate brachytherapy 1998 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), John C. Blasko, Peter Grimm, Haakon Ragde, (unknown), (unknown), John Sylvester, Thomas W. Griffin	108
10	Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA) 1998 ·The Prostate ·Michael L. Salgaller, Patricia A. Lodge, (unknown), (unknown), Douglas J. Loftus, Haakon Ragde, Gerald M. Kenny, M. Rogers, Alton L. Boynton, Gerald P. Murphy	95
11	Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer 1998 ·Urology ·Gerald P. Murphy, (unknown), Haakon Ragde, (unknown), Alton L. Boynton, Eric H. Holmes, (unknown), Georg Bartsch, Helmut Klocker, (unknown), Andreas Reissigl, David G. McLeod, Thomas H. Douglas, (unknown), James H. Gilbaugh	43
12	Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides 1997 ·The Prostate ·B.A. Tjoa, Sheila J. Erickson, Victoria Bowes, Haakon Ragde, Gerald M. Kenny, Oliver E. Cobb, Robert C. Ireton, M.J. Troychak, Alton L. Boynton, G.P. Murphy	103
13	Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma 1997 ·Cancer ·Haakon Ragde, John C. Blasko, Peter Grimm, Gerald M. Kenny, John E. Sylvester, (unknown), (unknown), William Cavanagh	215
14	Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer 1997 ·International Journal of Radiation OncologyBiologyPhysics ·Bradley R. Prestidge, (unknown), Peter Grimm, Haakon Ragde, William Cavanagh, John C. Blasko	84
15	Interstitial implantation techniques in prostate cancer 1997 ·Journal of Surgical Oncology ·John Sylvester, John C. Blasko, Peter Grimm, Haakon Ragde	64
16	Comparison of serum PSMA, PSA levels with results of cytogen-356 ProstaScint® scanning in prostatic cancer patients 1997 ·The Prostate ·Gerald P. Murphy, Robert T. Maguire, (unknown), Alan W. Partin, Wil B. Nelp, M.J. Troychak, Haakon Ragde, Gerald M. Kenny, Robert J. Barren, Victoria Bowes, (unknown), Eric H. Holmes, Alton L. Boynton	49
17	Evaluation and comparison of two new prostate carcinoma markers: Free-prostate specific antigen and prostate specific membrane antigen 1996 ·Cancer ·Gerald P. Murphy, Robert J. Barren, Sheila J. Erickson, Victoria Bowes, Robert L. Wolfert, Georg Bartsch, Helmut Klocker, (unknown), Andreas Reissigl, David G. McLeod, Thomas H. Douglas, Ted O. Morgan, Gerald M. Kenny, Haakon Ragde, Alton L. Boynton, Eric H. Holmes	52
18	SHOULD BRACHYTHERAPY BE CONSIDERED A THERAPEUTIC OPTION IN LOCALIZED PROSTATE CANCER? 1996 ·Urologic Clinics of North America ·John C. Blasko, Haakon Ragde, (unknown), John E. Sylvester, William Cavanagh, Peter Grimm	98
19	In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy 1995 ·The Prostate ·B.A. Tjoa, Sheila J. Erickson, Robert J. Barren, Haakon Ragde, Gerald M. Kenny, Alton L. Boynton, Gerald P. Murphy	44
20	Ultrasound-guided prostate biopsy Biopty gun superior to aspiration 1988 ·Urology ·Haakon Ragde, Hector C. Aldape, Charles M. Bagley	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact